From: PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity
PI3K
Dose/ schedule
Time above alpha 10x IC50 (h)
Time above beta 10x IC50 (h)
Time above delta 10xIC50 (h)
Time above gamma 10xIC50 (h)
AZD8835
α/δ
50 mg/kg BD d1/d2
24
0
PI-3065
δ
75 mg/kg QD
22